You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 9,849,122


✉ Email this page to a colleague

« Back to Dashboard


Title:Combination therapy
Abstract: Described herein are compounds and compositions for treating glaucoma and/or reducing intraocular pressure. Compositions may comprise an isoquinoline compound and a prostaglandin or a prostaglandin analog. Compounds described herein include those in which an isoquinoline compound is covalently linked to a prostaglandin or a prostaglandin analog, and those in which an isoquinoline compound and a prostaglandin free acid together form a salt.
Inventor(s): Kopczynski; Casey (Chapel Hill, NC), Lin; Cheng-Wen (Raleigh, NC), Sturdivant; Jill Marie (Chapel Hill, NC), deLong; Mitchell A. (Chapel Hill, NC)
Assignee: Aerie Pharmaceuticals, Inc. (Durham, NC)
Filing Date:Apr 29, 2016
Application Number:15/142,461
Claims:1. A compound according to formula (II): ##STR00041## or a pharmaceutically acceptable salt thereof, wherein: Y is phenylene; B is --NR.sub.1R.sub.2 or --CH.sub.2NR.sub.1R.sub.2; R.sub.1 and R.sub.2 are each independently hydrogen or C.sub.1-C.sub.4 alkyl; X.sub.1 and X.sub.2 are hydrogen; and PG is an acyl radical of latanoprost, bimatoprost, travoprost, tafluprost, AR-102, cloprostenol, unoprostone, or PGF.sub.2.alpha..

2. The compound of claim 1, wherein: B is --CH.sub.2NR.sub.1R.sub.2; and R.sub.1 and R.sub.2 are hydrogen.

3. The compound of claim 1, wherein PG is an acyl radical of latanoprost.

4. The compound of claim 1, wherein PG is an acyl radical of AR-102.

5. The compound of claim 1, wherein PG is an acyl radical of bimatoprost.

6. A composition comprising a compound of claim 1, and at least one of a buffer, a chelating agent, a tonicity agent, a preservative, a viscosity enhancer, a sugar or a sugar alcohol, or a surfactant.

7. The compound of claim 1, wherein PG is an acyl radical of travoprost.

8. A method of treating glaucoma in a subject in need thereof, comprising administering to the subject a compound of claim 1.

9. The method of claim 8, wherein the compound is administered topically to an eye of the subject.

10. A method of reducing intraocular pressure in a subject in need thereof, comprising topically administering to an eye of the subject a compound of claim 1.

11. A compound, wherein the compound is: ##STR00042## or a pharmaceutically acceptable salt thereof.

12. A composition comprising a compound of claim 11, further comprising at least one of a buffer, a chelating agent, a tonicity agent, a preservative, a viscosity enhancer, a sugar or a sugar alcohol, or a surfactant.

13. A method of treating glaucoma in a subject in need thereof, comprising administering to the subject a compound of claim 11.

14. The method of claim 13, wherein the compound is administered topically to an eye of the subject.

15. A method of reducing intraocular pressure in a subject in need thereof, comprising topically administering to an eye of the subject a compound of claim 11.

16. A compound according to formula (II): ##STR00043## or a pharmaceutically acceptable salt thereof; wherein Y is phenylene; B is --CH.sub.2NR.sub.1R.sub.2; R.sub.1 and R.sub.2 are hydrogen; X.sub.1 and X.sub.2 are hydrogen; and PG is an acyl radical of latanoprost.

17. A composition comprising a compound of claim 16, further comprising at least one of a buffer, a chelating agent, a tonicity agent, a preservative, a viscosity enhancer, a sugar or a sugar alcohol, or a surfactant.

18. A method of treating glaucoma in a subject in need thereof, comprising administering to the subject a compound of claim 16.

19. The method of claim 18, wherein the compound is administered topically to an eye of the subject.

20. A method of reducing intraocular pressure in a subject in need thereof, comprising topically administering to an eye of the subject a compound of claim 16.

21. The compound of claim 2, wherein PG is an acyl radical of bimatoprost.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.